Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial — Papers | ScholarIQ

Scholar IQ

Help

Try ScholarIQ free

Upload Records Snowball Search Search OpenAlex

About the database

ScholarIQanswers from OpenAlex

Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial

PaperCitations, authors & open-access status

6,550

Citations

2,015

Year

closed

OA Status

IDs:DOI PMID OpenAlex

Related on ScholarIQ

Marcelo Garrido

Gregory M. Lubiniecki

Marisa Dolled‐Filhart